Oliceridine Fumarate

Phase 3Small molecule

CChun Pan

Oliceridine Fumarate is one of 3 small molecule programs targeting Sedation. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Oliceridine FumarateNot yet recruiting

Oliceridine FumaratePhase 3

Not yet recruiting

Competition

Competitive Landscape

3 competitors in Oliceridine Fumarate

#DrugCompanyPhaseTrials

Ultiva

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

1 2

Oliceridine Fumarate

CChun Pan

Phase 3

1 3

Sufenta

LLeaf Vertical Inc.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

PreclinicalRecruiting

Sedation

NCT07707258

Clinical

Trials by Indication[1]

Oliceridine Fumarate1 trial

Efficacy and Safety Studies of Oliceridine Fumarate

Not yet recruiting·CChun Pan·Phase 4·NCT06454292·292 enrolled

Sedation1 trial

Hemodynamic and Oxygenation Profiles of Remimazolam Combined With Oliceridine Versus Sufentanil in Elderly Patients Undergoing Painless Gastrointestinal Endoscopy: A Randomized, Double-blind, Controlled Trial

Recruiting·BBaoshan Branch, Renji Hospital, Shanghai Jiao Tong University School of Medicine·Preclinical·NCT07707258·240 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Oliceridine Fumarate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Oliceridine Fumarate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Oliceridine Fumarate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Chun Pan company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: CChun Pan

Oliceridine Fumarate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Oliceridine Fumarate1 trial

Sedation1 trial

References

Drug Info

Quick Facts

Related News